Literature DB >> 24577631

Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population.

Zhenzhen Zheng1, Xiaoyan Guo, Qianqian Wei, Wei Song, Bei Cao, Rui Huang, Ruwei Ou, Xueping Chen, Huifang Shang.   

Abstract

Oxidative stress is involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). Serum uric acid (UA) has anti-oxidative effect. To clarify the associations between UA and sporadic ALS (SALS) in Chinese population. A total of 512 SALS patients and 501 age- and gender- matched healthy controls were included, with fasting serum UA evaluated. The ALS functional rating scale-Revised was used to assess disease severity, and the mean change of ALSFRS-R per month (△ALS-FRS-R/m) to assess its progression. Four hundred forty-five patients were followed up. Survival and progression were estimated according to quartiles and gender-specific quartiles of UA. The mean age of SALS patients was 53.3 ± 11.7 years. UA level of SALS was significantly lower than controls (p = 0.001). Male SALS had higher UA than female (p = 0.001). The occurrence of SALS was increased in the lowest, second and third quartiles compared with the highest quartile (p = 0.001). In the gender-specific analysis, increased occurrence was found in the lowest and second quartiles compared with third and fourth quartiles in both males and females SALS (p(f) = 0.001 and p(m) < 0.05). No correlation was found between △ALS-FRS-R/m and UA (p > 0.05), nor between SALS survival and UA. SALS patients have low level of serum UA than controls. Low level of uric acid may be associated with increased occurrence of SALS in Chinese population. Uric acid level may not contribute to the survival or progression of SALS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577631     DOI: 10.1007/s11011-014-9510-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  30 in total

Review 1.  Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C Bergeron
Journal:  J Neurol Sci       Date:  1995-05       Impact factor: 3.181

2.  Serum uric acid levels and the risk of Parkinson disease.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis.

Authors:  Stefano Zoccolella; Isabella Laura Simone; Rosa Capozzo; Rosanna Tortelli; Antonio Leo; Eustachio D'Errico; Giancarlo Logroscino
Journal:  J Neurol       Date:  2010-09-15       Impact factor: 4.849

4.  Dissociation between in vitro and in vivo epileptogenicity in a rat model of cortical dysplasia.

Authors:  Christoph Kellinghaus; Gabriel Möddel; Hiroshi Shigeto; Zhong Ying; Berit Jacobsson; Jorge Gonzalez-Martinez; Candice Burrier; Damir Janigro; Imad M Najm
Journal:  Epileptic Disord       Date:  2007-02-15       Impact factor: 1.819

5.  Uric acid levels predict survival in men with amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; May Zhang; Alejandro Quiroz Zárate; Matthew Jaffa; Hong Yu; Merit E Cudkowicz; Anne-Marie Wills
Journal:  J Neurol       Date:  2012-02-10       Impact factor: 4.849

6.  Urate as a predictor of the rate of clinical decline in Parkinson disease.

Authors:  Alberto Ascherio; Peter A LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B Bogdanov; Steven R Schwid; Marsha Tennis; Caroline M Tanner; M Flint Beal; Anthony E Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A Schwarzschild
Journal:  Arch Neurol       Date:  2009-12

7.  Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.

Authors:  Andrea Winquist; Kyle Steenland; Anoop Shankar
Journal:  Mov Disord       Date:  2010-05-15       Impact factor: 10.338

8.  Plasma urate and risk of Parkinson's disease.

Authors:  M G Weisskopf; E O'Reilly; H Chen; M A Schwarzschild; A Ascherio
Journal:  Am J Epidemiol       Date:  2007-06-20       Impact factor: 4.897

9.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Plasma urate and progression of mild cognitive impairment.

Authors:  Michael C Irizarry; Rema Raman; Michael A Schwarzschild; Lida M Becerra; Ronald G Thomas; Ronald C Peterson; Alberto Ascherio; Paul S Aisen
Journal:  Neurodegener Dis       Date:  2008-11-05       Impact factor: 2.977

View more
  9 in total

1.  Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Kjetil Bjornevik; Michael A Schwarzschild; Marjorie L McCullough; Laurence N Kolonel; Loic Le Marchand; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-26       Impact factor: 4.092

Review 2.  Urate as a Marker of Risk and Progression of Neurodegenerative Disease.

Authors:  Sabrina Paganoni; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 3.  ALS biomarkers for therapy development: State of the field and future directions.

Authors:  Michael Benatar; Kevin Boylan; Andreas Jeromin; Seward B Rutkove; James Berry; Nazem Atassi; Lucie Bruijn
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

4.  Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.

Authors:  Sabrina Paganoni; Katharine Nicholson; James Chan; Amy Shui; David Schoenfeld; Alexander Sherman; James Berry; Merit Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2017-09-21       Impact factor: 3.217

5.  Serum urate at trial entry and ALS progression in EMPOWER.

Authors:  ÉIlis J O'Reilly; Dawei Liu; Donald R Johns; Merit E Cudkowicz; Sabrina Paganoni; Michael A Schwarzschild; Melanie Leitner; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-09-28       Impact factor: 4.092

6.  Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China.

Authors:  QianQian Wei; XuePing Chen; ZhenZhen Zheng; Rui Huang; XiaoYan Guo; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

7.  Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis.

Authors:  Seong Il Oh; Soojeong Baek; Jin Seok Park; Liying Piao; Ki Wook Oh; Seung Hyun Kim
Journal:  J Clin Neurol       Date:  2015-10       Impact factor: 3.077

Review 8.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

9.  Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Fan Zhang; Qin Zhang; Yaqiong Ke; Jianbo Hao; Ling Lu; Nannan Lu; Xiling Chen
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.